Skip to main content
. 2018 Oct 3;16(6):7123–7130. doi: 10.3892/ol.2018.9547

Table IV.

Diagnostic performance of serum AKR1B10 in combination with AFP in patients with HCC.

AKR1B10/AFP HCC Non-HCC Total
AKR1B10 >1.5 ng/ml 78 63 141
± AFP >11.71 ng/ml
Negative for both 6 70 76
Total 84 133 217

AKR1B10, aldo-keto reductase family 1 member B10; AFP, α-fetoprotein; HCC, hepatocellular carcinoma.